Rhythm Pharmaceuticals schedules call on Prader-Willi syndrome trial data

June 12, 2026 4:01 PM

Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) announced it will host a conference call on June 13 at 9:00 a.m. ET to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found